TrialBritish journal of cancer2021

Safety and impact of dose reductions on efficacy in the randomised MONALEESA-2, -3 and -7 trials in hormone receptor-positive, HER2-negative advanced breast cancer.

Howard A Burris et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.